A model of magnetic nanoparticle transport and their effects in tumor areas: Assessment of desirable magnetic properties
Source abstract
Abstract
A mathematical model of the transport of drug loaded magnetic nanoparticles and their effects on tumor evolution is presented. The model is developed in the context of continuum mechanics and transport phenomena, with the main variables, such as interstitial fluid pressure and flow, nanoparticle, cell and oxygen concentrations, cell-phase velocities and pressures being described as continuous fields over the tumor and surrounding tissue. The evolution of tumor shape and size is obtained from the numerical solution of the model equations. Simulations are presented comparing the behavior in the absence of any drug, in the presence of drug loaded nanoparticles but without a magnetic field, and under the action of a magnetic field of varying intensity. It is observed that magnetic targeting can have a profound effect on the distribution of nanoparticles inside the tumor and a clearly apparent and quantitatively significant influence on its progression. With the aid of magnetic targeting, the otherwise almost inaccessible area, due to the effects of the interstitial fluid pressure and flow, can be exposed to significant and controlled nanoparticle concentrations. For this to be achieved, it suffices for the magnetically induced nanoparticle velocity to be a fraction of the interstitial fluid flow velocity, yet in the same order of magnitude. This assessment provides a guiding rule for the rational design of magnetic nanoparticles and the quest of suitable magnetic fields.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Mathematical Biology Tumor Growth · Nanoparticle-Based Drug Delivery · Microfluidic and Bio-sensing Technologies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (66)
Show source-provided references
1. Magnetic Drug Targeting: Preclinical in Vivo Studies, Mathematical Modeling, and Extrapolation to Humans10.1021/acs.nanolett.6b02261 ↗
2. On the closure of mass balance models for tumor growth10.1142/S0218202502001878 ↗
3. A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion10.1093/imammb/dqi005 ↗
4. Continuous and Discrete Mathematical Models of Tumor-induced Angiogenesis10.1006/bulm.1998.0042 ↗
5. A mathematical model of tumour-induced capillary growth10.1016/S0022-5193(85)80255-1 ↗
6. Transport of fluid and macromolecules in tumors. (I) Role of interstitial pressure and convection10.1016/0026-2862(89)90074-5 ↗
7. Transport of fluid and macromolecules in tumors. (II) Role of heterogeneous perfusion and lymphatics10.1016/0026-2862(90)90023-K ↗
8. Modelling solid tumour growth using the theory of mixtures10.1093/imammb/20.4.341 ↗
9. Computational challenges of tumor spheroid modeling10.1142/S0219720011005379 ↗
10. Numerical modeling of nanodrug distribution in tumors with heterogeneous vasculature10.1371/journal.pone.0189802 ↗
11. Nonlinear simulations of solid tumor growth using a mixture model: invasion and branching10.1007/s00285-008-0215-x ↗
12. Mathematical modeling in cancer nanomedicine: A review10.1007/s10544-019-0380-2 ↗
13. A Mathematical Model for Cisplatin Cellular Pharmacodynamics10.1016/S1476-5586(03)80008-8 ↗
14. A coupled mass transport and deformation theory of multi-constituent tumor growth10.1016/j.jmps.2020.103936 ↗
15. Fine-grained simulations of the microenvironment of vascularized tumours10.1038/s41598-019-48252-8 ↗
16. Three-dimensional multispecies nonlinear tumor growth—II: Tumor invasion and angiogenesis10.1016/j.jtbi.2010.02.036 ↗
17. Local and nonlocal phase field models of tumor growth and invasion due to ECM degradation10.1142/S0218202519500519 ↗
18. Microvascular permeability of normal and neoplastic tissues10.1016/0026-2862(86)90018-X ↗
19. Image-based spatio-temporal model of drug delivery in a heterogeneous vasculature of a solid tumor - Computational approach10.1016/j.mvr.2019.01.005 ↗
20. Transport of nanoparticles in magnetic targeting: Comparison of magnetic, diffusive and convective forces and fluxes in the microvasculature, through vascular pores and across the interstitium10.1016/j.mvr.2020.104007 ↗
21. The Fluid Mechanics of Cancer and Its Therapy10.1146/annurev-fluid-120710-101102 ↗
22. Quantifying the motion of magnetic particles in excised tissue: Effect of particle properties and applied magnetic field10.1016/j.jmmm.2015.05.069 ↗
23. Flow through interstitium and other fibrous matrices10.1113/expphysiol.1987.sp003085 ↗
24. Nonlinear modelling of cancer: bridging the gap between cells and tumours10.1088/0951-7715/23/1/R01 ↗
25. Multiscale modelling and nonlinear simulation of vascular tumour growth10.1007/s00285-008-0216-9 ↗
26. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs
27. Mathematical Modelling of Flow Through Vascular Networks: Implications for Tumour-induced Angiogenesis and Chemotherapy Strategies10.1006/bulm.2002.0293 ↗
28. Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: Clinical implications and therapeutic targeting strategies10.1016/j.jtbi.2005.12.022 ↗
29. Evaluation of Drug-Loaded Gold Nanoparticle Cytotoxicity as a Function of Tumor Vasculature-Induced Tissue Heterogeneity10.1007/s10439-018-02146-4 ↗
30. Pharmacokinetic/Pharmacodynamics Modeling of Drug-Loaded PLGA Nanoparticles Targeting Heterogeneously Vascularized Tumor Tissue10.1007/s11095-019-2721-5 ↗
31. Emergent Properties of Tumor Microenvironment in a Real-Life Model of Multicell Tumor Spheroids10.1371/journal.pone.0013942 ↗
32. Drug penetration in solid tumours10.1038/nrc1893 ↗
33. Numerical Investigation of Drug Delivery to Cancerous Solid Tumors by Magnetic Nanoparticles Using External Magnet10.1007/s11242-017-0893-1 ↗
34. Magnetic drug targeting during Caputo-Fabrizio fractionalized blood flow through a permeable vessel10.1016/j.mvr.2021.104262 ↗
35. Role of vascular normalization in benefit from metronomic chemotherapy10.1073/pnas.1700340114 ↗
36. Directing cell therapy to anatomic target sites in vivo with magnetic resonance targeting10.1038/ncomms9009 ↗
37. The behaviors of ferromagnetic nano-particles in and around blood vessels under applied magnetic fields10.1016/j.jmmm.2010.09.008 ↗
38. Solute dispersion of drug carrier during magnetic drug targeting for blood flow through a microvessel10.1063/5.0053645 ↗
39. On the transport of compact particles through solutions of chain-polymers10.1098/rspa.1973.0064 ↗
40. Applications of magnetic nanoparticles in biomedicine10.1088/0022-3727/36/13/201 ↗
41. Hindered transport of spherical macromolecules in fibrous membranes and gels10.1002/aic.690351102 ↗
42. Hindered transport in fibrous membranes and gels: Effect of solute size and fiber configuration10.1016/0021-9797(90)90110-A ↗
43. Magnetically assisted delivery of cells using a magnetic resonance imaging system10.1088/0022-3727/44/5/055001 ↗
44. Numerical modeling of drug delivery in a dynamic solid tumor microvasculature10.1016/j.mvr.2015.02.007 ↗
45. Magnetically assisted intraperitoneal drug delivery for cancer chemotherapy10.1080/10717544.2018.1455764 ↗
46. Open challenges in magnetic drug Targeting10.1002/wnan.1311 ↗
47. Impact of drug carrier shape, size, porosity and blood rheology on magnetic nanoparticle-based drug delivery in a microvessel10.1016/j.colsurfa.2022.128370 ↗
48. Effect of nanoparticle size, magnetic intensity, and tumor distance on the distribution of the magnetic nanoparticles in a heterogeneous tumor microenvironment10.1016/j.jmmm.2019.166089 ↗
49. Spatio-temporal investigation of doxorubicin in a 3D heterogeneous tumor microenvironment Biomed10.1088/2057-1976/ab7a53 ↗
50. Two-Dimensional Chemotherapy Simulations Demonstrate Fundamental Transport and Tumor Response Limitations Involving Nanoparticles10.1023/B:BMMD.0000048562.29657.64 ↗
51. Finite-element simulation of the start-up problem for a viscoelastic fluid in an eccentric rotating cylinder geometry using a third-order upwind scheme10.1007/BF00311813 ↗
52. Mathematical modelling of flow in 2D and 3D vascular networks: applications to anti-angiogenic and chemotherapeutic drug strategies10.1016/j.mcm.2005.05.008 ↗
53. Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside10.1016/j.trecan.2018.02.005 ↗
54. Design considerations for nanotherapeutics in oncology. Nanomedicine: Nanotechnology
55. Tumor heterogeneity and nanoparticle-mediated tumor targeting: the importance of delivery system personalization10.1007/s13346-018-0578-5 ↗
56. An upwind finite element scheme for high-Reynolds-number flows10.1002/fld.1650120402 ↗
57. A Front-Tracking Method for the Computations of Multiphase Flow10.1006/jcph.2001.6726 ↗
58. A Validated Multiscale In-Silico Model for Mechano-sensitive Tumour Angiogenesis and Growth10.1371/journal.pcbi.1005259 ↗
59. In-silico dynamic analysis of cytotoxic drug administration to solid tumours: Effect of binding affinity and vessel permeability10.1371/journal.pcbi.1006460 ↗
60. Emergent vascular network inhomogeneities and resulting blood flow patterns in a growing tumor10.1016/j.jtbi.2007.09.031 ↗
61. Vascular remodelling of an arterio-venous blood vessel network during solid tumour growth10.1016/j.jtbi.2009.04.005 ↗
62. Interstitial Fluid Flow and Drug Delivery in Vascularized Tumors: A Computational Model10.1371/journal.pone.0070395 ↗
63. A quantitative in silico platform for simulating cytotoxic and nanoparticle drug delivery to solid tumours10.1098/rsfs.2018.0063 ↗
64. Three-dimensional multispecies nonlinear tumor growth—I Model and numerical method10.1016/j.jtbi.2008.03.027 ↗
65. The effect of interstitial pressure on tumor growth: Coupling with the blood and lymphatic vascular systems10.1016/j.jtbi.2012.11.031 ↗
66. The effect of interstitial pressure on therapeutic agent transport: Coupling with the tumor blood and lymphatic vascular systems10.1016/j.jtbi.2014.04.012 ↗